Publications by authors named "Jacob M Fingret"
BMJ Open Ophthalmol
September 2021
Article Synopsis
- Biologics like adalimumab are being increasingly used to treat systemic uveitis, aiming to improve patient outcomes in vision preservation.
- A study involving 46 patients showed that most were able to discontinue or significantly reduce their corticosteroid use while effectively managing their uveitis.
- Results indicated that most patients maintained or improved their vision over an average follow-up of about 4.5 years, with a low relapse rate and no serious side effects reported.
